Naphthylnitrobutadienes as pharmacologically active molecules: Evaluation of the in vivo antitumour activity

Investigational New Drugs

Volumn 25, Issue 6, 2007, Pages 535-544

  Petrillo, Giovanni ^a   Fenoglio, Carla ^b   Ognio, Emanuela ^c   Aiello, Cinzia ^c   Spinelli, Domenico ^d   Mariggiò, Maria A ^e   Maccagno, Massimo ^a   Morganti, Stefano ^d   Cordazzo, Cinzia ^c   Viale, Maurizio ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY OF BARI   (Italy)

Author keywords

Antitumour activity; In vivo pharmacological activity; Nitrobutadiene derivatives

Indexed keywords

1,3 BUTADIENE DERIVATIVE; 1,4 BIS(1 NAPHTHYL) 2,3 DINITRO 1,3 BUTADIENE; 1,4-BIS(1-NAPHTHYL)-2,3-DINITRO-1,3-BUTADIENE; ANTINEOPLASTIC AGENT; METHYL 2 METHYLSULFANYL 5 (1 NAPHTHYL) 4 NITRO 2,4 PENTADIENOATE; METHYL 2-METHYLSULFANYL-5-(1-NAPHTHYL)-4-NITRO-2,4-PENTADIENOATE; NAPHTHALENE DERIVATIVE; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; COMPARATIVE STUDY; DRUG SCREENING; FEMALE; MOUSE; NUDE MOUSE; TOXICITY TESTING;

ANIMALS; ANTINEOPLASTIC AGENTS; BUTADIENES; FATTY ACIDS, UNSATURATED; FEMALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; NAPHTHALENES; TOXICITY TESTS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 39549101639     PISSN: 01676997     EISSN: 15730646     Source Type: Journal    
DOI: 10.1007/s10637-007-9065-4     Document Type: Article

References (21)

1. Pujol MD, Romero M, Sanchez I (2005) Synthesis and biological activity of new class of deoxygenated anticancer agents. Curr Med Chem Anticancer Agents 5:215-237 (Pubitemid 40645592)
2. Medarde M, Maya AB, Perez-Melero C (2004) Naphthalene combretastatin analogues: sunthesis, cytotoxicity and antitubulin activity. J Enzyme Inhib Med Chem 19:521-540 (Pubitemid 40057743)
3. Schwartsmann G, Ratain MJ, Cragg GM, Wong JE, Saijo N, Parkinson DR, Fujiwara Y, Pazdur R, Newman DJ, Dagher R, Di Leone L (2002) Anticancer drug discovery and development throughout the world. J Clin Oncol 20 (Suppl 15):47S-59S
4. Neidle S, Thurston DE (2005) Chemical approaches to the discovery and development of cancer therapies. Nat Rev Cancer 5:285-296 (Pubitemid 40488634)
5. Pakin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2:533-543
6. Ferlay J, Bray F, Pisani P, Parkin DM (2001) Globocan 2000: cancer incidence, mortality and prevalence worldwide, version 1.0 (IARC, CancerBase No 5). IARC Press, Lyon
7. Viale M, Ottone M, Chiavarina B, Mariggiò MA, Prevosto C, Dell'Erba C, Petrillo G, Novi M (2004) Preliminary evaluation in vitro of the inhibition of cell proliferation, cytotoxicity and induction of apoptosis by 1,4-bis(1-naphthyl)-2,3-dinitro-1,3-butadiene. Invest New Drug 22:359-367 (Pubitemid 39619813)
8. Novi M, Ottone M, Dell'Erba C, Barbieri F, Chiavarina B, Maccagno M, Viale M (2004) 1,4-Bis(1-naphthyl)-2,3-dinitro-1,3-butadiene: a novel anticancer compound effective against tumour cell lines characterized by different mechanisms of resistance. Oncol Rep 12:91 -96
9. Dell'Erba C, Chiavarina B, Fenoglio C, Petrillo G, Cordazzo C, Boncompagni E, Spinelli D, Ognio E, Aiello C, Mariggiò MA, Viale M (2005) Inhibition of cell proliferation, cytotoxicity and induction of apoptosis of 1,4-bis(1-naphthyl)-2,3-dinitro-1,3-butadiene in gastrointestinal tumour cell lines and preliminary evaluation of its toxicity in vivo. Pharmacol Res 52:271-282 (Pubitemid 40981929)
10. Viale M, Petrillo G, Chiavarina B, Mariggiò MA, Spinelli D, Aiello C, Dell'Erba (2005) Preliminary in vitro evaluation of the antitumour activity of 1-naphthyl-2-nitrobutadiene derivatives. "Abstract" Tumori 4 (Suppl):103
11. Dell 'Erba C, Mele A, Novi M, Petrillo G, Stagnaro P (1990) Synthetic exploitation of the ring-opening of 3,4-dinitrothiophene. A novel access to 1,4-dialkyl- and 1,4-diaryl-2,3-dinitro-1,3-butadienes. Tetrahedron Lett 31:4933-4936
12. Dell'Erba C, Mele A, Novi M, Petrillo G, Stagnaro P (1992) Synthetic exploitation of the ring-opening of 3,4-dinitrothiophene. Access to 1,4-disubstituted 2,3-dinitro-1,3-butadienes and 2,3-butanedione dioximes. Tetrahedron 48:4407-4418
13. Bianchi L, Dell'Erba C, Maccagno M, Morganti S, Petrillo, G, Rizzato, E, Sancassan, F, Severi, E, Spinelli, D, Tavani C (2006) Nitrobutadienes from β-nitrothiophenes: valuable building-blocksin the overall ring-opening/ring-closure protocol to homo- or hetero-cycles. Arkivoc (vii):169-185 (Pubitemid 43097066)
14. Dell'Erba C, Gabellini A, Novi M, Petrillo G, Tavani C, Cosimelli B, Spinelli D (2001) Ring-opening of 2-substituted 4-nitrothiophenes with pyrrolidine. Access to new functionalized nitro-unsaturated building blocks. Tetrahedron 57:8159-8165 (Pubitemid 32823509)
15. Manetti D, Ghelardini C, Bartolini A, Dei S, Galeotti N, Gualtieri F, Romanelli MN, Teodori E (2000) Molecular simplification of 1,4-diazabicyclo[4.3. 0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity. J Med Chem 43:4499-4507 (Pubitemid 32046874)
16. Crisòstomo FRP, Carrillo R, Leòn LG,Martìn, T Padròn, JM Martin, VS (2006) Molecular simplification in bioactive molecules: formal synthesis of (+)-muconin. J Org Chem 71:2339-2345
17. Montaguti P, Melloni E, Cavalletti E (1994) Acute intravenous toxicity of dimethyl sulfoxide, polyethylene glycol 400, dimethylformamide, absolute ethanol, and benzyl alcohol in inbred mouse strains. Arzneimittelforschung 44:566-570 (Pubitemid 24122322)
18. Nuber R, Teutsch HF, Nuber R (1980) Metabolic zonation in thioacetamide-induced liver cirrhosis. Histochemistry 69:277-288 (Pubitemid 11166165)
19. Katz NR (1992) Metabolic heterogeneity of hepatocytes across the liver acinus. J Nutr 122:843-849
20. Jungermann K, Thurman RG (1992) Hepatocyte heterogeneity in the metabolism of carbohydrates. Enzyme 46:33-58 (Pubitemid 23032626)
21. Jungermann K, Kietzmann T (2000) Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology 31:255-260 (Pubitemid 30078586)